[Cambridge session] She Started It: A Film Screening

Jun 15 2017https://www.eventbrite.co.uk/e/cambridge-session-she-started-it-a-film-screening...



96% of venture capitalists are men1. Women still account for less than 10% of founders for high growth firms2 and earn only 12.9% of computer science degrees3. "She Started It" gives a new face to the image of the tech entrepreneur: a female face.

Join Johnson & Johnson Innovation, JLABS and the Innovation Forum for a film screening of "She Started It", a new documentary film that follows five trailblazing young female entrepreneurs through their journeys of entrepreneurship.

The movie screening will be followed by a panel discussion featuring local influential women in business. All ages are welcome!

View the trailer for the film here: https://www.youtube.com/watch?v=hcGGrUx666s

1Fortune
2"Sources of Economic Hope" by Kauffman Foundation
3Computing Research Association study



Agenda:
17:30 | Registration Opens & Networking Reception
18:30 | Film Screening of "She Started It"
19:30 | Panel Discussion
20:30 | Programme Close


Speakers:
Karin Conde-Knape | VP of Cardiovascular & Metabolism Scientific Innovation, Johnson & Johnson Innovationread bio»
Tanya Hutter | Darwin College Research Fellow at the Department of Chemistry, University of Cambridge read bio»
Fiona Nielsen | Founder and CEO, RePositive and DNAdigest read bio»


Fees:
FREE | General Public


Location:
Kaetsu Lecture Theatre
Murray Edwards College 

Speakers:
Karin Conde-Knape | VP of Cardiovascular & Metabolism Scientific Innovation, Johnson & Johnson Innovation
Karin Conde-Knape is Vice President of Scientific Innovation, Cardiovascular & Metabolic at Johnson & Johnson Innovation. In this role, her main responsibilities are to identify, evaluate, set and manage external collaborations within the CVM area in Europe, Israel and Asia Pacific bringing additional value to the Johnson and Johnson pipeline. Previously, Karin was Global Head of Discovery in the CVM DTA at Roche where she was responsible for all the Early Research efforts as well as the Translational Biomarker and experimental medicine group. While at Roche, Karin was directly or indirectly responsible for identifying and managing numerous external collaborations with well renowned institutions worldwide. In addition, throughout her career at Roche, she had several roles, including laboratory head, project leader, head of pharmacology and co-department head in the CV and Metabolism Disease and Translational Area, both in the US and in Switzerland. She was responsible for setting and implementing the pharmacology strategy for the portfolio in the CVM group in areas such as Diabetes, Atherosclerosis, Dyslipidemia, Kidney, and CV disease. Karin received her PhD in Nutritional Sciences from the University of Connecticut, and completed her post-doctoral fellowship at Columbia University.



Tanya Hutter | Darwin College Research Fellow at the Department of Chemistry, University of Cambridge
Tanya Hutter is currently a Darwin College Research Fellow at the Department of Chemistry at the University of Cambridge. Her research focuses on chemical sensors and bio-sensors. After completing her PhD in Physical Chemistry in Cambridge in 2013, she founded SensorHut to develop and commercialise a chemical sensor technology for gas detection.






Fiona Nielsen | Founder and CEO, RePositive and DNAdigest
Bioinformatics scientist specialised in genome analysis with 15 years of experience in software development and project management. Fiona left her job at Illumina Cambridge in 2013 to pursue her vision of enabling efficient genomic data sharing and founded the charity DNAdigest. In August 2014 she founded Repositive as a spin out of DNADigest.

Event Partner:



Media Partner:

Share